Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLEXANE for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 6 adverse event reports in the FDA FAERS database where CLEXANE was used for Atrial fibrillation.

Most Reported Side Effects for CLEXANE

Side Effect Reports % Deaths Hosp.
Exposure during pregnancy 28 19.2% 0 8
Anaemia 14 9.6% 5 9
Haemorrhage 12 8.2% 8 4
Renal failure 9 6.2% 8 2
Tachycardia 9 6.2% 0 9
Abortion spontaneous 8 5.5% 0 0
Cerebellar haemorrhage 8 5.5% 0 7
Foetal exposure during pregnancy 7 4.8% 1 5
Melaena 7 4.8% 4 3
Hepatic enzyme increased 6 4.1% 0 0
Pulmonary embolism 6 4.1% 4 1
Death 5 3.4% 5 2
Haematemesis 5 3.4% 4 1
Hypotension 5 3.4% 4 0
Premature baby 5 3.4% 1 4

Other Indications for CLEXANE

Thrombosis prophylaxis (35) Product used for unknown indication (27) Prophylaxis (13) Hypercoagulation (7) Deep vein thrombosis (6) Maternal exposure timing unspecified (6)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

CLEXANE Full Profile All Atrial fibrillation Drugs CLEXANE Demographics CLEXANE Timeline